FDA and representatives of the generic drug industry meet quarterly to discuss topics related to the implementation of GDUFA.
Similar Posts
Hetero Labs Limited, Unit-IX – 09/26/2025
Hetero Labs Limited, Unit-IX – 09/26/2025. Country: India. Record Type: 483Kabana Skin Care LLC – 710232 – 07/18/2025
CGMP/Finished Pharmaceuticals/AdulteratedPharmaceutical Quality Resources
FDA provides resources on pharmaceutical quality topics, including information on regulations, guidance documents, and compliance programs.Sunscreen Innovation Act | SIA
The Sunscreen Innovation Act (SIA) was enacted on November 26, 2014 to provide an alternative process for the review of safety and effectiveness of nonprescription sunscreen active ingredients.Generic Drugs Program Monthly and Quarterly Activities Report
Monthly and quarterly metrics of the FDA Generic Drugs Program.Anesthetic and Analgesic Drug Products Advisory Committee Roster
This page contains the AADPAC roster, which lists the current members and the current number of vacancies for the committee.
